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CHLOROTHIAZIDE AS AN ADJUNCT IN THE TREATMENT 
OF HYPERTENSIVE CARDIOVASCULAR DISEASE 
JOHN R. CALDWELL, M.D.* AND ROV J. KAR.IALA, M . D . ' ^ * 
It is a remarkable tribute to the group effort in modern medical science that 
ehlorothiazidet in less than one year from the date of reporting its synthesis' has been 
carefully studied and reported upon and made available for wide use in the treatment 
of edema and hypertension.'-' 
We report here its use in patients with sustained high blood pressure which has 
affected the structure or function of the heart as evidenced by cardiomegaly on chest 
x-ray or left ventricular hypertrophy on EKG. Particular attention was given to the 
mode of blood pressure measurement'-' in order to avoid misleading conclusions which 
might result if more variable casual blood pressures were used. All of the patients 
reported here were on moderate salt restriction as a basic part of their antihypertensive 
therapy, some on 400 mg. sodium diets and some with instructions to avoid highly 
salted foods and to refrain from the addition of salt at the table or in cooking. 
A group of eight patients, who were under treatment with rauwolfia or rauwolfia 
and hydralazine,'1^+ came in once a week for basal blood pressure determinations for 
one month prior to starting chlorothiazide as an addition to their program of treatment. 
Thereafter, basal blood pressure determinations were made once a week after chloro-
thiazide was instituted. The findings on these patients are summarized in Table I . The 
average blood pressure for the group before chlorothiazide was 171 systolic and 105 
diastolic. During the period of treatment wilh chlorothiazide, the average blood 
pressure for the group was 147 systolic and 89 diastolic, representing a reduction of 
24 mm. of mercury systolic and 16 mm. of mercury diastolic for the group. The blood 
pressure was lowered in every instance. Of the eight patients reported, four continued 
on the same treatment plus chlorothiazide with blood pressures at lower levels; three 
v^ ere able to discontinue reserpine+ or reserpine and hydralazine and one decreased 
the dose of reserpine. All had good blood pressure control on chlorothiazide as an 
adjunct or alone. The majority of the patients felt well and experienced no undesirable 
side effects attributable to the drug. 
A second group of eight patients in the out-patient clinic were under treatment 
with ganglionic blocking agents and used home blood pressure recordings as a guide to 
therapy. The.se patients and others on ganglionic blocking agents are educated to 
check their blood pressure in the sitting and standing position just before time for 
the dose of the ganglionic blocking drug. They are usually instructed to omit the dose 
of ganglionic blocking drug if the systolic standing blood pressure is below 120 mm. 
of mercury just before time for the dose. With this home guide to therapy, faithfully 
followed, few patients encounter harmful effects from an overdosage. The same method 
of checking blood pressure just prior to the dose of mecamylamine!; was used as a 
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melhod ot making suitable reductions in the dosage of this drug when chlorothiazide 
w.is .idded to the program. The findings on these patients, all with hypertensive 
cardiovascular disease treated w ith mecamv lamine and all using home blood pressure 
recordings as a guide to the dosage of mecamvlamine, are listed in Table I I . The 
iMoiid |-iressiire readings listed in Table II represent averages by the week of all standing 
blood pressures thus measured for a number of weeks before starting chlorothiazide 
and alter starting chlorothiazitle. Usually this represented a one month pre-and post-
treatment period, although observations extending to two months or more have been 
essentially the same. The average blood pressures in the pretreatment period were 
1 "4 ssstolic .ind 10'> diastolic with a reduction of 23 mm. systolic and 10 mm. diastolic 
as the average for the group. The blood pressures were lower in every case when 
chlorothiazide was used. Three patients were able to discontinue mecamylaminc; two 
vsere able to reduce the dose by 509f of the previous amount and one to reduce the 
dose 30'; of (be previous amount (Fig. 1,2). Two other patients continued on the 
s.ime dose of mecamvlamine with lower blood pressures and considerable clinical 
improvement. The average doses of mccamylamine were 28 mg. per day prior to the 
institution of chlorothiazide and with chlorothiazide the average dose was 13 mg. 
per day for the group. These patients generally experienced relief from fatigue, less 
dvspnea, less nocturia and a better work tolerance, indicating a gain from additional 
reduction of the blood pressure. At the same time, they benefited by a reduction or 
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Figure 1 
Numbers in parenthesis al the bottom of each dashed rectangle are the number of home blood 
pressure readings averaged for the week. Home readings were just prior to time for dose of mecamy-
lamine ilnvcrsinci. .oiise<.)iiinlh these icprcseni the highest readings. In this case. Basal Blood 
I'rcssiirc deietmin.iiions in the out-patient clinic \*ere done several hours after the medication w-is 
lanen at home. Data on this patient is also tabulated in Table I I . 
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Figure 2 
Graphic record of BP from patient with pie-treatment fixed blood pressure of 170/110. Eight months 
prior to study, treatment with Reserpine had produced depression and fatigue. 
Note orthostatic hypotensive effect of mecamylamine with no change in sitting BP. Chlorothiazide 
alone lowered both sitting and upright BP without much orthostatic difference. 
elimination of the undesirable effects of ganglionic blocking agents, particulariy a 
reduction in constipation, dryness of the mouth and blurred vision. These benefits 
were not restricted to patients treated with mecamylamine but also pcntolinium* dosage 
was reduced or eliminated in other patients not reported in Table I I , 
In addition to the above sixteen patients, eighteen others were studied in the 
hospital and the out-patient clinic but sufficient follow-up data is not available for 
tabulation. Nevertheless, clinical observations on these patients seemed worthy of report. 
The drug proved to be particulariy useful in a number of patients meriting 
hypotensive treatment who had moderate or severe hypertensive cardiovascular disease 
and who could not be treated with customary measures. For example, two patients 
developed paralytic ileus on relatively small doses of ganglionic blocking drug. One 
patient, E. C. Case No. 29 47 56. on mecamylamine was able to continue with the 
drug at a reduced dose of mccamylamine by the use of chlorothiazide without sub-
sequent paralytic ileus. Another patient, Mrs. R. Y., Case No. 63 46 02, had developed 
paralytic ileus on chlorisondaminet and, at x-ray later, was found to have a 
stenotic loop of bowel at the terminal ileum. A month after chlorisondamine had been 
stopped, the patient had a resection of this loop of intestine for regional ileitis. There 
was a breakdown in the anastomosis and an ileostomy was performed. The patient 
*Ansolvsen by Wyeth 
Ecolid by Ciba 
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Table I 
BEFORE CHLOROTHIAZIDE AfJ^R C HI.OROTHIAZinF. 
Name. Age. Race. 
Sex. Case No. Diagnosis 
C. R. 
56. W 
Male 
I I 75 56 
1IC\ 1) 
M . S. 
36. N 
Female 
76 64 29 
HCVD 
Epistaxis 
Cardiac insufficiency 
J. A. 
50, W 
Male 
86 96 36 
HCVD 
R. W. 
51. N 
Mate 
72 62 30 
HCVD 
L. S. 
52. W 
Male 
77 96 18 
HCVD 
Encephalomalacia 
(L) internal capsule 
F. Y. 
64, W 
Male 
71 14 21 
HCVD 
Chronic brain 
syndrome 
Arteriosclerosis 
Azotemia (mild) 
Z. S. 
65, W 
Male 
03 78 97 
HCVD 
J. D. 
47, N 
Male 
71 44 21 
HCVD 
Treatment 
Rauwolfia* 
too mg./d. 
Rx irregularly 
with Rauwolfia 
SR too mg. 
q.i.d. 
Reserpine 0.5 
mg. b.i.d. 
Reserpine 0.5 
mg. q./d. 
Hydralazine 
100 mg. q.i.d. 
Rauwolfia IOO" 
mg. b.i.d. 
Hydralazine 
too mg. q.i.d. 
Reserpine 0.5 
mg. q./d. 
Reserpine 0.25 
mg. q./d. 
Hydralazine 25 mg. 
q.i.d. 
Caused depression 
Reserpine 0.5 
mg. q./d. 
Hydralazine 25 
mg. q.i.d. 
BASAL 
BLOOD PRESSURE 
ONCE A WEEK 
Weeks Weeks 
Change in Treatment 
Subjective 
Results 
Difference in 
Blood Pressure 
4lh 168 106 
3rd 166/106 
2nd 
Ist 
Ave. 167/106 
Ist 140/88 
2nd 122/86 
3rd 126/70 
4th 150/92 
Ave. 134/84 
Continue Rauwolfia 
Chlorothiazide 500 
mg. q. 12 h. 
Transient 
paresthesias 
Fell improved 
—33/—22 
4lh 
3rd 134/84 
2nd 142/88 
Ist 180/120 
Ave. 152/IOt 
Ist 
2nd 118/70 
3rd 122/70 
4th 
Ave. 120/70 
Continued Rauwolfia 
Chlorothiazide 500 
mg. q. 12 h. 
l eclmg well 
No dyspnea 
—33/—29 
4th 158/96 
3rd 
2nd 
Ist 
Ave. 158/96 
Ist. 118/70 
2nd 190/120 
3rd 132/90 
4th 132/80 
Ave. 143/90 
Reserpine decreased 
lo 0.5 mg. q./d. 
Chlorothiazide 500 
mg. q. 12 h. 
Felt better 
Enuresis once ^ 
after 1 month on 
Chlorothiazide 
4th 160/103 
3rd 170/104 
2nd 170/104 
Ist 134/90 
Ave. 160/100 
1st 178/100 
2nd 142/90 
3rd 132/88 
4ih 106/74 
Ave. 139/85 
Continue Hydralazine 
and Reserpine 
Chlorothiazide 500 
mg. q. 12 h. 
Improved 2 , 
Less fatique 
—21/—15 a 
2 
4th 180/100 
3rd 186/112 
2nd 
Ist 160/90 
Ave. 175/100 
Ist 154/76 
2r»d 138/88 
3rd 178/98 
4th 
Ave. 156/87 
Stopped Chlorothiazide 
after 2 wks. Continued 
Rauwolfia and 
Hydralazine. 
Added Mecamylamine 
2.5 mg. q. 12 h. 
N.iUM.- 1 .111.1 n o ^ 
appetite while taking ^ 
Chlorothiazide 
Felt worse s~ 
—19/—13 
4th 
3rd 
2nd I 9 0 / I I 0 
Ist 174/106 
Ave. 182'108 
Ist 172 114 
2nJ 147/106 
3rd 
j 4th 
Ave. I 5 9 / I I 0 
Stopped Reserpine 
Chlorothiazide 500 
mg. q. 12 h. 
No complaints 
Fell well 
—23/+2 
4ih 
3rd 170/93 
2nd 166/88 
1st 154/92 
Ave. 160/90 
Ist 154/84 
2nd 148/82 
3rd 152/90 
4ih 
Ave. 151/85 
Stopped Reserpine 
and Hydralazine 
Chlorothiazide 500 
mg. q. 12 h. 
No complaints 
Felt well 
—9/—5 
4lh 
3rd 184/124 
2nd 200/130 
1st 206/108 
Ave. 196/120 
Ist 154/98 
2nd 200/110 
3rd 158/98 
4th 192/112 
Ave. 176/104 
Continued Reserpine 
and Hydralazine 
Chlorothiazide I 
Gram q. A M 
Continued lo have 
headaches 
Felt well 
—20/—16 
Table I I 
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had previously had a severe depressive reaction to reserpine so that all antihvpertensive 
drugs were withheld during several weeks in the hospital at the time of her surgery. 
.She developed signs of progressive left ventricular hvperlrophv associated with high 
blood pressure. Reserpine seemed contraindiciited in view of the previous depressive 
reaction with suicidal trends, ganglionic blocking agents seemed contraindicated in 
view of the complications associated with her intestinal surgery. Methyl reserpate* 
parenterally was ineffective in lowering her pressure. We resorted to chlorothiazide 
and with the use of this drug as the sole antihypertensive agent, her blood pressure 
came close to normal and remained at satisfactory levels. 
Another patient. M. M., Case No. 89 55 57, was a man who had had a depressive 
reaction lo reserpine for treatment of hypertensive cardiovascular di.seasc. and was 
referred by another doctor for evaluation. Between his first visit and waiting for a 
hospital bed. he developed a severe gastrointestinal hemorrhage presumably from peptic 
ulcer. The blood pressure was widelv variable in view of repeated hemorrhage and 
transfusion. When the patient had massive hemorrhage, blood pressure would be very 
Ims. 11 .insttisions would result in extreme rises in pressure and subsequently further 
hemorrhage would occur. We did not want to use reserpine in view of his previous 
ticpressive reaction and preferred not to use ganglionic blocking agents in view of 
Ihe intestinal hemorrhage. On treatment with chlorothiazide as the sole antihypertensive 
.lueni. along with blood transfusions, his blood pressure gradually stabilized at much 
lower levels and we were eventually able to control him with small doses of mecamy-
lamine plus chlorothiazide for maintenance. 
r. Y., Case No. 71 14 21, was scheduled for a nephrolithotomy for renal calculus. 
He had had transient cerebral vascular insufficiency, sustained blood pressure elevation 
,ind lelt ventricular hypertrophy by EKCi. It seemed desirable to lower his pressure 
before surgerv and in the postoperative period. We were hesitant about giving him 
rauwolfia since general anesthesia would soon be indicated and we have encountered 
a number of serious hvpotensive reactions during general anesthesia in patients who 
have been under treatment with rauwolfia derivatives. Treatment with chlorothiazide 
reduced his blood pressure in the pre-and post-operative periods and appeared to be 
satisfactorv as the sole antihypertensive agent. 
One patient, H. B.. C ase No. 89 33 18, who developed a psychosis about a 
month following a subarachnoid hemorrhage seemed to be benefited by chlorothiazide. 
Reserpine was discontinued because he had a severe agitated depression. The use of 
uanclionic blocking agents was impractical due to his psychotic behavior. Blood 
pressures were reduced somewhat bv chlorothiazide and this was helpful in differ-
entiating his psvcholic svmptoms from symptoms which could conceivably have been 
due to hypertensive encephalopathv. One hospitalized patient. Z. R., Case No. 80 95 11. 
uiih mild a/olemia, showeil slight blood pressure reduction when chorothiazide was 
used for one week as the only treatment, l ater, with the addition ot intramuscular 
reserpine. little bene!it was gained and considerable drowsiness and stuffiness of the 
nose resulted. .She was treated with chlorothiazide alone and the follow-up period was 
loo brief for a long term evaluation of the benefit but the basal blood pressure was 
•Su..3ll8 Ciba 
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150/94 after one month on this treatment. Pre-trealment basal blood pressures were 
all above 170/104. 
Wilh respect to side effects and possible toxic effects of chlorothiazide, one 
patient is described who stopped the drug due to nausea; L. S.. Case No. 77 96 18, 
listed in Table I . Three other patients discontinued the medication due to undesirable 
side effects. In one patient, this was described as a nausea and heartburn. Another 
patient after taking the drug for four days frequently had a feeling of pinching in the 
chest and of blood rushing to the head. She stopped taking the medicine and felt 
better. Another patient had noticed diuretic effect from chlorothiazide but also 
dizziness, faintness. and weakness with an exacerbation of neuromuscular chest pains. 
She discontinued the drug, resumed it one week later and again had the same un-
desirable symptoms. These last three cases described all had features of neurotic 
reactions and it is possible that some of the undesirable effects described were in 
Ihe nature of placebo reaction to the new medication. This seems especially likelv 
in view of the minimum of side effects reported hy most other investigators with 
chlorothiazide. 
Three patients with renal insufficiency associated with hypertensive cardiovascular 
disease were studied in the hospital, maintained on a 400 mg. sodium diet and were 
given chlorothiazide as part of treatment for their hypertensive disease. One of these 
patients, T. L.. Case No. 89 80 98 had Grade IV fundi and a serum creatinine of 
3 mg. percent. The serum phosphorous was 5.4 mg. percent. His highest serum 
sodium was 137 Meg./L. At a time of maximum chlorothiazide effect at 2 Gm./d. 
the serum sodium was 127. potassium 2.9, chloride 83 and CO: was 27.4. Chlorothia-
zide in this patient caused a remarkable potentiation in the postural hypotensive effect 
of inversine and the greatest orthostatic hvpotension occurred at a time when the 
serum sodium, chloride and potassium were lowest. Patient A. C, Case No. 86 73 70 
had encephalopathy and renal failure with serum creatinine 7.4 and phosphorous 9.2 
mg. percent. She also showed a reduction in serum sodium, potassium, chloride and 
a rise in COj when chlorothiazide I Gm./d. was added to a 400 mg. sodium diet. 
A. M., Case No. 86 85 15. with recurrent pulmonary edema and renal failure had 
serum creatinine 7.5. serum phosphorous 9.0 mg. percent. His highest serum sodium 
was 137. He was on a 400 mg. sodium diet, chlorothiazide and mecamylamine. 
Diuresis occurred with relief of pulmonarv edema. The serum sodium fell to 120. 
potassium 3.0, chloride 88 and CO2 increased to 27.6. 
There were no apparent adverse effects in these three patients from the depletion 
of sodium, pota.ssium and chloride which occurred. The average change in serum 
electrolytes in Meq./L for the three patients with renal insufficiency was for .sodium 
-7.2. for potassium -0.7, for chloride -14.1. for C02-f6.4. These electrolyte changes 
are more marked than those described in most patients on chlorothiazide treatment.' 
This may be due to a combination of renal insufficiency, salt restricted diet and 
chlorothiazide. Although the depletion of sodium and chloride and potassium was 
associated with clinical improvement and good hypotensive effects in these patients 
on concurrent antihypertensive drug treatment, the hazard of salt depletion and low 
salt syndrome did exi.st. The changes elicited were reversible readily with cessation of 
the drug and/or added salt to the diet. 
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The changes in serum electrolytes of these patients with renal insufficiency were 
of greater magnitude than those described by Laragh^ and Ford.' Slowly, progressive 
renal insufficiency as evidenced by a rising creatinine and NPN occurred in two of 
these three cases but was difficult to relate to undue hypotensive effect or possible 
nenhro-toxic effect of chlorothiazide. In the majority of patients on a higher salt 
int,ike with chlorothiazide as reported by Freis' no such depletion of sodium, potassium 
and chloride occurred. A patient reported in Table H, S. D., Case No. 43 98 64, 
I .ilso charted in Fig. 3) followed a dose of 1 Gm. of chlorothiazide every twelve 
hours for a period of two months, with no depletion of electrolytes. This patient 
arbitrarily stopped salt restriction and gained weight not due to edema. It seems 
likely that this improvement was due to a less monotonous diet and a feeling of 
well-being associated with a reduction in the dose of his ganglioplegic drug. It is 
interesting that on a liberal salt intake, this patient continued to have lower average 
blood pressures than before chlorothiazide. He was able to reduce his dose of 
mecamvlamine bv 50 per cent. Three weeks after the start of chlorothiazide at 2 Gm./d. 
serum sodium was 137, pota.ssium 6.1, chloride 101, CO: was 21.7. Six weeks after 
the start of chlorothiazide his serum sodium was 137, potassium 3.7, chloride 108 
and COJ was 22.6. It would appear that the danger of salt depletion is not great as 
long as Ihe oral intake of salt is not severely restricted and as long as there is no 
unusual loss through repeated vomiting or diarrhea or inability to eat. In the patient 
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Figure 3 
HI' record iif patient unable to work for .3 months because of recurrent pulmonary edema until 
chlorothia/ule was instituted. Coinciilent with starting chlorothiazide note: ( I ) lower average weekly 
sitting BP (solid rectangles). (2) enhancement of orthostatic hypotensive effect of mecamylamine 
(dash lines for average weekly standing BP) and. (3) reduction in dose of mecamylamine by more 
than 50^ . 
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\uth malignant hypertension T. L.. Case No. 89 80 98 salt depletion from chlorothiazide 
occurred in relation to a reduction in blood pressure with marked orthostatic hypo-
tension. This fact suggests that salt depletion is the principle mode of hvpotensive action 
of this novel diuretic in hypertensive patients. Against this theory is the observation 
that serum electrolytes are relatively unchanged in most of the patients on chlorothiazide 
when no salt restriction is advocated. Prolonged use of chlorothiazide at 2 Gm./d. 
on a relatively liberal salt intake in S. D., Case No. 43 98 64, was not associated 
with salt depletion. At the same time, there was a maintained blood pressure re-
duction and also a reduction in the dose of mecamylamine. This suggests some mode 
of action other than salt depletion for the h\potensive effects. 
The major benefit of this new diuretic agent for patients with hypertensive di.sease 
is the advantage of being able to reduce or omit less desirable hypotensive agents. 
By virtue of this change, the weakness, stuffy nose and lethargy some patients ex-
perience with rauwolfia may be reduced and the blurred vision, dryness of the mouth, 
constipation and sexual impotence associated with ganglioplegic drugs mav be reduced. 
.Many patients experience a sense of well-being or relief from fatigue. This is little 
wonder in view of the fact that there is a reduction in rauwolfia and ganglionic 
blocking drugs as part of the response lo the new drug. Studies done elsewhere by 
1-reis' and Wilkins' have also shown that some of their hypertensive patients treated 
with chlorothiazide alone had adequate control of hypertension. Also, Freis' has 
studied normotensive patients and found that there is no significant reduction in blood 
pressure in such cases and that there is a specificity for this drug which is unique. 
Laragh, et al* has shown that in doses up to 8 Gm./d. no side effects were noted and 
that in thirty patients on usual doses of 1 Gm./d. no toxic effects were noted except 
erythema in one case. The uric acid was higher in patients studied by Laragh et aP 
and characteristic hypochloremic alkalosis was produced. Ford' postulated that the 
mechanism of diuretic action was due to an inhibition of renal tubular reabsorption 
of sodium. Schreiner' showed in thirteen patients with chronic renal failure that the 
drug was chloruretic and the poorest clinical responses to the drug were in those 
patients with chronic renal failure. Perhaps the greatest danger is salt depletion and 
progressive renal insufficiency. 
When chlorothiazide was used in the treatment of 34 patients with hypertensive 
cardiovascular disease, the drug was found to be an effective antihypertensive agent, 
usually permitting a reduction and occasionally elimination of the dose of other anti-
hypertensive drugs. In the majority of patients for the period of time studied, it 
seemed to be of most value as an adjunct to therapy rather than sufficient as the .sole 
form of treatment. According to a clinical estimate results could be graded as follows: 
excellent 15. good 11, fair 4, poor 4. In a group of eight patients treated with 
rauwolfia or rauwolfia and hydralazine, the change in the average blood presstin.' 
after treatment wilh chlorothiazide was -24 mm. of mercury systolic and -16 mm. of 
mercury diastolic for the group. In a group of eight patients treated with mecamylamine 
the average change in blood pressure was -23 mm. of mercury systolic and -10 mm. 
of mercury diastolic. In eighteen other patients brief sketches of the most pertinent 
clinical features are described along with some comment about their response to the 
drug. Three patients with renal insufficiency were on salt restricted diets and with 
46 
Caldwell and Karjala 
chlorothiazide treatment developed salt depletion which was reversible and not dele-
terious but is noted as a possible hazard of therapy. Side effects were usually absent. In 
those patients who did develop undesirable reactions, these side effects are briefly 
discussed. The usual dose was 500 mg. every twelve hours, in the morning and at 
night. The range of dosage was 500 mg. once daily to 2 Gm. daily. In most cases, 
dosage w.is continuous daily. Speculations regarding the mode of action are presented. 
The time period was short for these observations embracing not more than three 
months al the most; however, the work of Freis' and Wilkins' covers larger numbers 
ot p.iiients over longer periods of time, and they report similar results. 
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